Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Mise à jour : Il y a 4 ans
Référence : NCT00866775

Femme et Homme

Extrait

This is an 18-week, double-blind, multicenter study with gradual conversion from previous antiepileptic therapy to eslicarbazepine acetate monotherapy in subjects with partial epilepsy.


Critère d'inclusion

  • Epilepsy With Simple or Complex Partial Onset Seizures

Liens